Pharma Deals Review, Vol 2007, No 79 (2007)

Font Size:  Small  Medium  Large

Actavis Acquires Abrika and ZiO Zdorovje

Business Review Editor

Abstract


Actavis Group has gained control of two further companies, Abrika Pharmaceuticals in a deal value worth up to €181 M and ZiO Zdorovje for €47 M.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.